Racial disparities in creatinine-based kidney function estimates among HIV-infected adults

Ethnicity and Disease

Volumn 26, Issue 2, 2016, Pages 213-220

  Anker, Naomi ^a,b   Scherzer, Rebecca ^a   Peralta, Carmen ^a   Powe, Neil ^a   Banjeree, Tanushree ^a   Shlipak, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic Kidney Disease; Estimated Glomerular Filtration Rate; Human Immunodeficiency Virus; Mortality; Racial Disparities

Indexed keywords

CREATININE; ILLICIT DRUG; SERUM ALBUMIN;

ADULT; AFRICAN AMERICAN; ARTICLE; ASSOCIATION; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEATH; DIABETES MELLITUS; DRUG USE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEINURIA; RACE DIFFERENCE; RETROSPECTIVE STUDY; AGED; CHRONIC KIDNEY FAILURE; COMPLICATION; ETHNOLOGY; METABOLISM; MIDDLE AGED; REGISTER; VETERAN;

ADULT; AGED; CREATININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; VETERANS;

EID: 84964988344     PISSN: 1049510X     EISSN: 19450826     Source Type: Journal    
DOI: 10.18865/ed.26.2.213     Document Type: Article

References (36)

1. Adih WK, Selik RM, Hu X. Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic). 2011;10(1):5-11. http://dx.doi.org/10.1177/1545109710384505. PMID:21088284.
2. Palella FJ Jr, Baker RK, Moorman AC, et al; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27-34. http://dx.doi.org/10.1097/01. qai.0000233310.90484.16. PMID:16878047.
3. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. The impact of HIV on chronic kidney disease outcomes. Kidney Int. 2007;72(11):1380-1387. http://dx.doi. org/10.1038/sj.ki.5002541. PMID:17805235.
4. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197(11):1548-1557. http:// dx.doi.org/10.1086/587994. PMID:18422458.
5. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2012;59(5):628-635. http://dx.doi.org/10.1053/j.ajkd.2011.10.050. PMID:22206742.
6. De Wit S, Sabin CA, Weber R, et al; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008;31(6):1224-1229. http://dx.doi. org/10.2337/dc07-2013. PMID:18268071.
7. Estrella MM, Wyatt CM, Pearce CL, et al. Host APOL1 genotype is independently associated with proteinuria in HIV infection. Kidney Int. 2013;84(4):834-840. http://dx.doi.org/10.1038/ ki.2013.203. PMID:23715117.
8. Seaberg EC, Muñoz A, Lu M, et al; Multicenter AIDS Cohort Study. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005;19(9):953-960. http://dx.doi. org/10.1097/01.aids.0000171410.76607.f8. PMID:15905677.
9. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61(1):195-202. http://dx.doi.org/10.1046/ j.1523-1755.2002.00094.x. PMID:11786101.
10. Szczech LA, Grunfeld C, Scherzer R, et al. Microalbuminuria in HIV infection. AIDS. 2007;21(8):1003-1009. http://dx.doi. org/10.1097/QAD.0b013e3280d3587f. PMID:17457094.
11. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010;121(5):651-658. http://dx.doi.org/10.1161/CIRCULATIONAHA. 109.898585. PMID:20100969.
12. Alves TP, Hulgan T, Wu P, et al. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol. 2010;5(12):2269-2275. http://dx.doi. org/10.2215/CJN.00520110. PMID:20876679.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470. http://dx.doi. org/10.7326/0003-4819-130-6-199903160-00002. PMID:10075613.
14. Peralta CA, Lin F, Shlipak MG, et al. Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations. Nephrol Dial Transplant. 2010;25(12):3934-3939. http://dx.doi.org/10.1093/ndt/gfq299. PMID:20519233.
15. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612. http://dx.doi. org/10.7326/0003-4819-150-9-200905050-00006. PMID:19414839.
16. Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract. 2009;111(1):c39-c48. http://dx.doi. org/10.1159/000178978. PMID:19052469.
17. Beringer PM, Owens H, Nguyen A, et al. Estimation of glomerular filtration rate by using serum cystatin C and serum creatinine concentrations in patients with human immunodeficiency virus. Pharmacotherapy. 2010;30(10):1004-1010. http://dx.doi.org/10.1592/phco.30.10.1004. PMID:20874037.
18. Driver TH, Scherzer R, Peralta CA, et al. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS. 2013;27(14):2291-2299. http://dx.doi. org/10.1097/QAD.0b013e328362e874. PMID:23669156.
19. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16(2):459-466. http://dx.doi.org/10.1681/ ASN.2004060447. PMID:15615823.
20. Wyatt CM, Schwartz GJ, Owino Ong'or W, et al. Estimating kidney function in HIVinfected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS One. 2013;8(8):e69601. http:// dx.doi.org/10.1371/journal.pone.0069601. PMID:23950899.
21. Seape T, Gounden V, van Deventer HE, Candy GP, George JA. Cystatin C-and creatinine-based equations in the assessment of renal function in HIV-positive patients prior to commencing Highly Active Antiretroviral Therapy. Ann Clin Biochem. 2016;53(Pt 1):58-66. PMID:25766385.
22. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. http://dx.doi.org/10.1056/NEJMoa041031. PMID:15385656.
23. Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med. 2007;147(1):19-27. http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00004. PMID:17606957.
24. Shlipak MG, Matsushita K, Ärnlöv J, et al; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932-943. http://dx.doi.org/10.1056/NEJMoa1214234. PMID:24004120.
25. Tangri N, Inker LA, Tighiouart H, et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol. 2012;23(2):351-359. http:// dx.doi.org/10.1681/ASN.2011070663. PMID:22173699.
26. Backus LI, Gavrilov S, Loomis TP, et al. Clinical Case Registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc. 2009;16(6):775-783. http://dx.doi.org/10.1197/jamia.M3203. PMID:19717794.
27. Scherzer R, Estrella M, Li Y, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS. 2012;26(7):867-875. http://dx.doi.org/10.1097/ QAD.0b013e328351f68f. PMID:22313955.
28. Scherzer R, Gandhi M, Estrella MM, et al. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIVpositive male veterans. AIDS. 2014;28(9):1289-1295. http://dx.doi.org/10.1097/ QAD.0000000000000258. PMID:24922479.
29. Levey AS, Greene T, Kusek JW, Beck GL, Group MS. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). Journal of the American Society of Nephrology: JASN. 2000(11):155A.
30. Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004;27(suppl 2):B22-B26. http:// dx.doi.org/10.2337/diacare.27.suppl-2.B22. PMID:15113778.
31. USGAO. Veterans Health Care: Use of VA Services by Medicare-eligible Veterans. Washington, DC; 1994.
32. Choi AI, Vittinghoff E, Deeks SG, Weekley CC, Li Y, Shlipak MG. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS. 2011;25(10):1289-1298. http://dx.doi.org/10.1097/ QAD.0b013e328347fa16. PMID:21516027.
33. Arlet JB, Ribeil JA, Chatellier G, et al. Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study. BMC Nephrol. 2012;13(1):83. http://dx.doi.org/10.1186/1471-2369-13-83. PMID:22866669.
34. Inker LA, Wyatt C, Creamer R, et al. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012;61(3):302-309. http://dx.doi.org/10.1097/ QAI.0b013e31826a6c4f. PMID:22842844.
35. Fine DM, Wasser WG, Estrella MM, et al. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol. 2012;23(2):343-350. http://dx.doi.org/10.1681/ASN.2011060562. PMID:22135313.
36. Peters B, Post F, Wierzbicki AS, et al. Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach. HIV Med. 2013;14(suppl 1):1-11. http://dx.doi. org/10.1111/j.1468-1293.2012.01055.x. PMID:23121515.